Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Prosight Management, LP Stock Portfolio

$359Million– No. of Holdings #44

Prosight Management, LP Performance:
2024 Q1: 0%YTD: 0%2023: -5.58%

Performance for 2024 Q1 is 0%, and YTD is 0%, and 2023 is -5.58%.

About Prosight Management, LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Prosight Management, LP reported an equity portfolio of $359.5 Millions as of 31 Mar, 2024.

The top stock holdings of Prosight Management, LP are STTK, ADCT, GLPG. The fund has invested 9.3% of it's portfolio in SHATTUCK LABS INC and 8.8% of portfolio in ADC THERAPEUTICS SA.

The fund managers got completely rid off ORIC PHARMACEUTICALS (ORIC), QUIDELORTHO (QDEL) and GRAPHITE BIO (GRPH) stocks. They significantly reduced their stock positions in NUVATION BIO INC (NUVB), KEZAR LIFE SCIENCES INC (KZR) and PRIVIA HEALTH GROUP INC (PRVA). Prosight Management, LP opened new stock positions in ROIVANT SCIENCES LTD (ROIV), BRIDGEBIO PHARMA INC (BBIO) and CYTOKINETICS INC (CYTK). The fund showed a lot of confidence in some stocks as they added substantially to ALKERMES PLC (ALKS), ERASCA INC (ERAS) and ORTHOPEDIATRICS CORP (KIDS).
Prosight Management, LP Equity Portfolio Value
Last Reported on: 15 May, 2024

Prosight Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Prosight Management, LP made a return of 0% in the last quarter. In trailing 12 months, it's portfolio return was 2.52%.

New Buys

Ticker$ Bought
roivant sciences ltd19,604,400
bridgebio pharma inc18,228,300
cytokinetics inc17,177,000
guardant health inc9,696,100
kelly svcs inc8,731,100
immunovant inc6,300,450
pfizer inc5,966,250
maravai lifesciences hldgs i5,197,320

New stocks bought by Prosight Management, LP

Additions to existing portfolio by Prosight Management, LP

Reductions

Ticker% Reduced
nuvation bio inc-87.8
kezar life sciences inc-71.37
privia health group inc-65.95
pacira biosciences inc-63.49
biocryst pharmaceuticals inc-37.28
option care health inc-32.8
prothena corp plc-25.73
medtronic plc-18.18

Prosight Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
oric pharmaceuticals-14,520,000
design therapeutics-742,000
graphite bio-3,542,080
veradigm-1,888,200
quidelortho-8,764,400
spyre therapeutics-1,183,600
shockwave medical-952,800

Prosight Management, LP got rid off the above stocks

Sector Distribution

Prosight Management, LP has about 77.4% of it's holdings in Healthcare sector.

Sector%
Healthcare77.4
Others21.7

Market Cap. Distribution

Prosight Management, LP has about 10.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP42.7
MID-CAP24
UNALLOCATED21.7
LARGE-CAP10.3
MICRO-CAP1.3

Stocks belong to which Index?

About 60.6% of the stocks held by Prosight Management, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200051.5
Others39.3
S&P 5009.1
Top 5 Winners (%)%
VKTX
viking therapeutics inc
126.5 %
KURA
kura oncology inc
47.7 %
CRBP
corbus pharmaceuticals hldgs
46.9 %
MRVI
maravai lifesciences hldgs i
32.6 %
NUVB
nuvation bio inc
31.7 %
Top 5 Winners ($)$
KURA
kura oncology inc
6.6 M
STTK
shattuck labs inc
4.7 M
VKTX
viking therapeutics inc
1.8 M
MRVI
maravai lifesciences hldgs i
1.3 M
CRBP
corbus pharmaceuticals hldgs
1.3 M
Top 5 Losers (%)%
PRTA
prothena corp plc
-29.3 %
ABCL
abcellera biologics inc
-20.2 %
RLAY
relay therapeutics inc
-17.0 %
TXG
10x genomics inc
-13.9 %
MGTX
meiragtx hldgs plc
-13.5 %
Top 5 Losers ($)$
MGTX
meiragtx hldgs plc
-3.8 M
PRTA
prothena corp plc
-2.4 M
ABCL
abcellera biologics inc
-2.1 M
BBIO
bridgebio pharma inc
-2.0 M
CYTK
cytokinetics inc
-1.7 M

Prosight Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Prosight Management, LP

Prosight Management, LP has 44 stocks in it's portfolio. About 62% of the portfolio is in top 10 stocks. MGTX proved to be the most loss making stock for the portfolio. KURA was the most profitable stock for Prosight Management, LP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions